ArticleEuropean journal of population = Revue europeenne de demographie2025
National Life Expectancy Lags Behind Benchmark Progress and the Role of Smoking: An International Comparison.
Article in European journal of population = Revue europeenne de demographie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mortality Dynamics in Low-Mortality Countries: An Introduction to the Special Issue.European journal of population = Revue europeenne de demographie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Countries with low mortality show uneven success in improving longevity. Smoking-still a dominant health risk-is a major determinant of these divergent trajectories. Our study aims to determine: a) the continuing influence of smoking on national mortality trends, and b) the extent to which other factors are preventing countries from realizing their health potential. Using mortality data from 20 low-mortality countries (1950-2019), we quantify life expectancy and age-specific mortality differences as calendar years behind the current longevity frontier, defined as record smoking-eliminated life expectancy. We find that current life expectancy largely reflects smoking-eliminated records from two decades ago, with a notable gender paradox across most countries: men are moving closer to the optimal health benchmarks, while women are drifting further away, although men still bear a greater burden of past smoking. While longevity leaders differ from laggards mainly in mortality at advanced ages, laggards show also extensive developmental delays throughout most of the working ages and the second half of life. Our results highlight the diminishing effect of smoking and the role of additional adverse factors in delayed mortality improvement. However, the positive effects from smoking declines have not yet been fully realized, as evidenced by the still comparatively high reduction in development delays after eliminating smoking. Nevertheless, the realization of further health potential largely depends on countries' ability to manage health in old age, including the increasing burden of chronic disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.